Conrad-Admin – Page 4

05.10.2022

Prof. Dr. Peter Rehling, director of the Institute for Cell Biochemistry, UMG. Photo: MBExC

05.10.2022

ERC Advanced Grant for Peter Rehling

MBExC member Peter Rehling, director of the Department for Cellular Biochemistry at the University Medical Center receives another ERC Advanced Grant of the European Research Council.

04.10.2022

Viola Priesemann takes up professorship at the University of Göttingen

On 1st October 2022, physicist and MBExC member Viola Priesemann has taken up a professorship in the field of theroretical physics at the University of Göttingen. Since 2017, she leads […]

16.08.2022

Prof. Dr. med. Tobias Moser, Director of the Institute for Auditory Neuroscience Göttingen, UMG. Photo: MBExC / spförtner

16.08.2022

Tobias Moser among Falling Walls Life Sciences Winners 2022

Tobias Moser is one of ten winners of Falling Walls 2022 in the category Life Sciences. The Falling Walls Foundation annually selects top projects worldwide that shape the future of […]

12.08.2022

Left: Concept drawing of combination of optical cochlear implant (oCI) with gene therapy product (top), close-up of waveguide-based oCI prototype for excitation with red light (bottom). Middle: Top view of the cochlea. Optical excitation of the neurons allows specific areas of the cochlea to be targeted for excitation. Right: Cross-section through the cochlea. Source: Keppeler/Moser (UMG)

12.08.2022

State of Lower Saxony promotes the preclinical development of the optical cochlear implant

The state of Lower Saxony and the Volkswagen Foundation approve funding for scientists at the UMG and the MBExC Cluster of Excellence of about 1 milion euros of the “SPRUNG” […]

12.08.2022

Left: Concept drawing of combination of optical cochlear implant (oCI) with gene therapy product (top), close-up of waveguide-based oCI prototype for excitation with red light (bottom). Middle: Top view of the cochlea. Optical excitation of the neurons allows specific areas of the cochlea to be targeted for excitation. Right: Cross-section through the cochlea. Source: Keppeler/Moser (UMG)

12.08.2022

State of Lower Saxony promotes the preclinical development of the optical cochlear implant

The state of Lower Saxony and the Volkswagen Foundation approve funding for scientists of the UMG and the MBExC Cluster of Excellence of about 1 milion euros of the "SPRUNG" (formerly: “Niedersächsisches Vorab”) for the development of the optical cochlear implant for the restoration of hearing in humans.

22.07.2022

Unique technology platform at the MBExC Cluster of Excellence combines cellular electrophysiology and optogenetics

New technology platform combines high-throughput recordings of cellular electrophysiology of isolated cardiomyocytes and neurons and their optical stimulation with light.